Test Module 2

How have country-based malaria experts adapted to the double challenge of malaria and COVID-19? What successes have they achieved, and where are the remaining gaps?  In a virtual forum on 3 September, 10 Ministry of Health representatives shared their experiences and reflections; you can watch their presentations below.

On 4 September, participants heard from senior political and health leaders from 2 regions that are heavily impacted by malaria; you will find below the presentations of WH

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• INFOSAN Quarterly Summary, 2020 #2

  During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

  Roles: Everyone: All Users

  Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

  Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

• Amid continued progress, trachoma elimination programmes set their sights on 2030

  Almost two decades of global work has drastically reduced the number of people at risk of blindness from trachoma from 1.5 billion in 2002 to under 137 million in May 2020 – a 91% decrease. Also in 2002, there were an estimated 7.6 million people with trachomatous trichiasis (TT); by May 2020, this figure had dropped by 74% to 2 million. The 2020 figures represent decreases of 4% and 20%, respectively, since the corresponding 2019 estimates.

  Roles: Everyone: All Users

  Regions: China, Iran , Nepal

  Topics: Climate and Environment, Global Health, Global Women's Issues